Rabab Reenaers

Rabab Reenaers is a researcher in the Mycobacteriology unit at the Institute of Tropical Medicine, Antwerp, Belgium. Her work focuses on tuberculosis and Mycobacterium tuberculosis, with expertise in drug susceptibility testing, antimicrobial resistance, and diagnostic methods. She has contributed to multiple publications in high-impact journals including Scientific Reports, Microbiology Spectrum, and Diagnostic Microbiology and Infectious Disease.

Her research spans Mycobacteriology, Tuberculosis, Antimicrobial Resistance, Bacterial Genetics, and Drug Susceptibility Testing. She investigates the genetic basis of drug resistance in tuberculosis, evaluates molecular diagnostic tools like GeneXpert MTB/RIF Ultra, and develops optimized culture techniques for Mycobacterium tuberculosis. Her work emphasizes improving tuberculosis diagnosis and treatment in resource-limited settings through laboratory innovations.

Analysis of her 2023-2025 publications reveals a concentrated focus on laboratory methodologies for tuberculosis control. Key themes include the impact of Mycobacterium tuberculosis genetic diversity on pretomanid susceptibility, culture isolation from non-invasive samples like tongue swabs, RNA preservation techniques, and detection of rifampicin resistance mutations. Her research bridges fundamental microbiology with clinical applications to enhance global tuberculosis management.

Rabab Reenaers operates within the Mycobacteriology research team at the Institute of Tropical Medicine, which maintains extensive international collaborations across Africa and Europe. The team specializes in developing and validating diagnostic protocols, studying drug resistance mechanisms, and contributing to tuberculosis control programs through evidence-based laboratory science.